Arslan, S. Et Al. 2018. Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures. 2nd International Cell Death Research Congress .

Arslan, S., ÜNAL, S., Gökçe, T., ATASOY, B. M., GÜNDÜZ, O., & KARADEMİR, B., (2018). Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures . 2nd International Cell Death Research Congress

Arslan, Sema Et Al. "Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures," 2nd International Cell Death Research Congress, 2018

Arslan, Sema Et Al. "Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures." 2nd International Cell Death Research Congress , 2018

Arslan, S. Et Al. (2018) . "Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures." 2nd International Cell Death Research Congress .

@conferencepaper{conferencepaper, author={Sema Arslan Et Al. }, title={Combination of First Generation Proteasome Inhibitor Bortezomib with Temozolomide and Radiotherapy in Glioblastoma 2D and 3D Cell Cultures}, congress name={2nd International Cell Death Research Congress}, city={}, country={}, year={2018}}